ty and mortality in patients undergoing non-cardiac surgery or vascular surgery. [1] [2] [3] Hypertension is a risk factor for potential coronary artery disease. Thus, evaluation of the cardiovascular system in patients with hypertension is important to predict perioperative morbidity and mortality before undertaking non-cardiac surgery. A variety of scoring systems and imaging strategies have been developed to predict such adverse cardiovascular events. [4] [5] [6] [7] [8] However, low predictive accuracy and poor clinical utility have limited the use of risk indices in current clinical practice and currently, there is no gold standard to effectively predict postoperative complications, length of hospital stay, or the possibility of mortality. Preoperative evaluations of the cardiovascular system that use chest radiography, electrocardiogram (ECG), echocardiography and laboratory studies are limited. For example, one limitation is the timing of an evaluation; if an evaluation is made during a time during which that particular parameter is stable, there is difficulty in detecting a small but significant deterioration in cardiovascular functional. While echocardiog-raphy has been utilized to assess cardiac risks, adding echocardiographic results have not demonstrated to improve risk assessment.
9)
Therefore, postoperative measurements of B-type natriuretic peptide (BNP) in certification of patients for perioperative events are clinically important but still not evaluated. The purpose of this study is to evaluate the relationship between post-operative BNP levels and the duration of hospital stay in hypertensive patients. In addition, this study attempts to assess normal left ventricular (LV) systolic function after elective orthopedic surgery.
Subjects and Methods

Study population
This prospective investigation was a single-center, observational cohort study. A total of ninety-seven consecutive patients with hypertension fulfilled the inclusion criteria and underwent scheduled orthopedic surgery (total hip or knee replacement) at the author's university hospital from May 2005 through August 2010.
The enrolled subjects were divided into 2 groups. Group I included patients that were hospitalization for 30 days or longer, while Group II included patients that were hospitalized for less than thirty days.
Cardiovascular risks were evaluated before surgery for spinal, epidural or general anesthesia by a cardiologist and an anesthetist according to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
10) These operations were performed in a usual manner without any clinical evidence of a significant fluid and electrolyte imbalance or cardiac failure. This study excluded patients with the following: had undergone an emergency operation; had a LV dysfunction (ejection fraction <50%), renal insufficiency (serum creatinine level >2.0 mg/dL); or had a history of ischemic heart disease, stroke, severe valvular heart disease, or peripheral vascular disease. In addition, patients were excluded patients if they had experienced a prolonged postoperative hospital stay due to operative causes such as a wound infection, bilateral operations, or re-operation. The study was approved by the local ethics committee and written informed consent was obtained from each study participant.
Data collection
Preoperative data were obtained within 7 days before a patient's scheduled operation, which included demographic data, 12-lead ECG recording, chest posteroanterior, medical and medication history, surgical history, physical examination and other biochemical tests. Age, gender, the presence of diabetes mellitus and dyslipidemia, blood pressure, body mass index, pre-and-postoperative BNP and preoperative hemoglobin levels were verified. The following clinical data were recorded: intravenous fluid intake, urinary output on the day of operation, and the total amount of blood transfused.
The following postoperative evaluations were performed for each patient within 24 hours of completing surgery: physical examination, chest PA, ECG, and laboratory tests. All patients underwent aconventional 2-dimensional and Doppler echocardiographic examinations for the assessment of ventricular systolic and diastolic functions. The Framingham criteria were used for defining postoperative heart failure.
11)
B-type natriuretic peptide measurement and assay
Plasma BNP and hemoglobin levels were measured on preoperative and postoperative day 1. A venous blood sample, taken for BNP measurement, was collected in a tube containing lithium-heparin and transported to the laboratory at room temperature. Patients were asked to lie at rest in a supine position for thirty (30) minutes, in order to eliminate any confounding effect of posture and exercise on plasma levels to the extent possible, before taking a preoperative blood sample. The Bayer ADVIA Centaur TM immunoassay operation (Bayer Healthcare LLC, Diagnostic division, Leverkusen, Germany) was used to measure plasma BNP levels.
Clinical outcome
The clinical outcomes of this study were evaluated during the hospitalization and follow-up periods. The primary end point was the predictive power of BNP levels for postoperative length of hospital stay. The secondary end point included non-cardiac death, cardiac death, myocardial infarction, development of congestive heart failure, and re-hospitalization. Cardiac death was defined as having experienced 1) sudden death that could not be explained by any other non-cardiovascular complications, or 2) gradual death caused by progressive heart failure and other known cardiac risk factors.
Myocardial infarction was defined as having a cardiac Troponin I (cTnI) increase above the 99th percentile of the upper limit (cTnI >0.032 ng/mL). Congestive heart failure was diagnosed by physical examination and interpretation of chest X-ray images by a radiologist as consistent with these complications.
Statistical analysis
Normally distributed continuous variables are expressed as the mean and standard deviation. Categorical data are presented as the absolute value and percentage. The Student's t-test and chi-square test, or Fisher's exact test, were used for normally distributed continuous and categorical variables, respectively. Variables that appeared to be significant on univariate analysis were entered into the model of multivariate analysis to determine independent factors associated with prolonged hospitalization. The odds ratios (OR) were given with 95% confidence intervals (CI).
To establish a BNP cut-off value with the appropriate sensitivity and specificity, receiver operating characteristic (ROC) curves were plotted and the area under the curve was estimated. Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS). All data have been analyzed with SPSS correlation and multiple linear regression models (SPSS v.18.0; SPSS Inc., Chicago, IL, USA). ROC curve was made using Medcalc version 9.6.
Results
Patient characteristics and echocardiographic data
The age of patients ranged from 52 to 70 years with a mean age The transfusion and intraoperative Intake and Output data showed no significant differences between these 2 groups. Table 2 showed differences in echocardiographic parameters between the 2 groups; however, this difference was not statistically significant.
B-type natriuretic peptide level and prolonged hospital stay
A correlation between postoperative BNP level and prolonged hospital stay was remarkable, as shown in Table 1 . Fig. 1 shows a boxplot of postoperative BNP levels in each group. There was a significant difference noted in the postoperative BNP level between the 2 groups. The mean postoperative BNP level of Group I was 6483.93± 11147.79 pg/mL as compared to that of Group II was 1708.03±6118.22 pg/mL (p=0.031). The preoperative BNP levels of Group I tended to be higher, but there was no statistical difference in the preoperative BNP level between these 2 groups (3477.24±6796.62 pg/mL for Group I vs. 1750.68±4510.28 pg/mL for Group II, p=0.24). Thus far, this study has illustrated that a significant correlation was displayed between the length of hospitalization and the postoperative BNP level.
Receiver operating characteristic curves demonstrated postoperative BNP levels as the predictors of hospital stay of 30 days or more with areas under the curve of 0.774 (95% CI, 0.679-0.070, p<0.001) (Fig. 2) . A BNP over 217.5 pg/mL had a sensitivity of 80.6% and specificity of 66.7% for predicting a postoperative hospital stay of 30 days or more.
Clinical outcome and predictors
Postoperative cardiac events occurred in 8 patients during the follow-up period (8.2%): one patient with cardiac death, 2 patients with myocardial infarction, one patient with cerebral infarction, and 4 patients required re-hospitalization due to congestive heart failure. There were 10 non-cardiac deaths, which were caused by either disease progression or surgical complications (10.3%). There was no statistically difference in the postoperative cardiac events between these two groups. Using logistic regression analysis, the univariate predictors of prolonged hospitalization were older age, postoperative elevated BNP level, preoperative lower hemoglobin and intravenous fluid intake ( Table 3) . The only independent predictor of prolonged hospitalization through the multivariate regression analysis model adjusting for age, postoperative BNP level, preoperative hemoglobin, postoperative transfusion and intravenous fluid intake was a postoperative elevated BNP level (OR; 1.020, 95% CI; 1.002-1.050, p=0.049) ( Table 4) .
Discussion
This prospective study proves the value of postoperative BNP level, which may play a role in predicting clinical outcome. Postoperative BNP levels are significantly associated with prolonged hospital stay, especially in hospitalization of over 30 days after non-cardiac surgery in hypertensive patients. Nevertheless, postoperative BNP levels are not predictive of postoperative cardiac events. The usefulness of the postoperative BNP cut-off level of 217.5 pg/mg was associated with an increased postoperative hospital stay.
Alternative methods of perioperative cardiac risk evaluation
Determination of preoperative risks in the elderly patients remains an important challenge for cardiology. Several indices have been developed, including the ACC/AHA guidelines, the revised cardiac index, the Goldman index, and preoperative echocardiography. However, these indices have limitations as prognostic value and some are quite complicated. 6) As previous studies have demonstrated that changes in N-terminal pro-B-type BNP (NT-proBNP) were related to adverse outcomes in acute coronary syndromes and acute decompensated heart failure, 12)13) NT-proBNP levels should contribute to the evaluation of prognosis during the perioperative period. The median preoperative NT-proBNP level of patients who had expired during the follow-up period was significantly higher than that of the survivors (795 pg/mL vs. 269 pg/mL, p=0.002). The median difference between pre-and postoperative NT-proBNP levels of expired patients was significantly higher than that of the survivors (5336 pg/mL vs. 665 pg/mL, p=0.010).
14) Preoperative NT-proBNP levels above the optimal discriminatory threshold of 457 pg/mL, determined by ROC curve analysis were associated with occurrences of postoperative cardiac events (OR; 10.5, 95% CI; 1.9 to 56.6; p=0.006).
15)
Another study demonstrated that both high sensitivity C-reactive protein (hs-CRP) and NT-proBNP had additional value in the prediction of postoperative cardiac events in patients undergoing vascular surgery. In addition, a combined elevation of hs-CRP and NT-proBNP carried a seven-fold higher risk for postoperative cardiac events.
16)
Previous studies and the advantages of the B-type natriuretic peptide levels B-type natriuretic peptide was first discovered in the porcine brain. However, it is actually secreted by both atrial and ventricular myocytes. 17) This prohormone is released during hemodynamic stress, that is, when the ventricle is dilated, hypertrophic, or subjected to increased cardiac wall tension. Prohormone BNP is cleaved into 2 polypeptides: inactive NT-pro-BNP and bioactive peptide BNP. BNP causes arterial vasodilation, diuresis, and natriuresis, and reduces activities of the renin-angiotensin-aldosterone and the sympathetic nervous system.
18)
Assays for BNP levels are commercially available and these biomarkers for heart failure are the most extensively used. Such testing is recommended among the current guidelines for hospital admission, discharge and re-hospitalization of heart failure patients.
Plasma BNP levels are powerful predictors of death and major adverse cardiovascular events in patients with a stable coronary artery disease, acute coronary syndrome, and congestive heart failure.
19)20)
Recently, several studies have confirmed that elevated preoperative BNP levels in patients, who had undergone non-cardiac or cardiac surgery, were associated with increased risks for mortality and morbidity during the follow-up period. [21] [22] [23] [24] An additional study has suggested that preoperative BNP and/or cTnI levels might assist in differentiating patients who are at very low risk for perioperative cardiac events from those who would require more detailed cardiovascular tests and optimization of therapies before undergoing major non-cardiac surgery.
25)
A significant study concerning postoperative BNP levels as a predictor of postoperative complications and outcomes in patients after open heart surgery was published.
Hutfless et al. 26) found that the highest postoperative BNP level had been associated with a prolonged hospital stay and one-year mortality. They documented that there had been a significant difference in the highest postoperative BNP level between the group that was hospitalized <10 days postoperatively and the group that had prolonged hospital stay for 10 days or more (750 pg/mL vs. 1190 pg/mL; p<0.001).
They also documented significant differences in median levels of the highest postoperative BNP level between 11 patients who had deceased within a year (1265 pg/mL) and patients who had under- gone open-heart surgery but were alive after one year (793 pg/mL) (p<0.01).
In consideration of the mechanism of elevated BNP levels after non-cardiac surgery, surgery by itself can cause stress such as anemia, blood pressure fluctuation, fluid imbalance and activation of the sympathetic nervous system, especially, in hypertensive patients.
B-type natriuretic peptide is released in response to ventricular wall stress. Thus, the consideration is that increased net (including intraoperative fluids) intravenous fluids are associated with increased postoperative BNP levels after surgery. Therefore, the assumption is that postoperative BNP levels may be related to diastolic dysfunction of the heart. Though small in scale, the theoretical mechanism on the increased BNP levels postoperatively may well be explained in this manner.
In conclusion, a moderately elevated postoperative BNP level above 217.5 pg/mL would predict delayed discharge from hospital for these 97 hypertensive patients with normal systolic function undergoing non-cardiac surgery. This study documented that postoperative BNP levels were not associated with perioperative cardiac complications, but could predict the length of hospital stay after non-cardiac surgery in hypertensive patients.
Nevertheless, this investigation could not document the fact that preoperative BNP levels were associated with prolonged hospital stays or cardiac events.
Measurements of postoperative BNP concentrations may aid in monitoring or actively guiding the level of therapeutic adjustment after surgery.
Post-operative BNP levels are comprehensive predictive factors in the postoperative period that is affected by preoperative BNP levels, fluid intake and output, underlying cardiovascular disease, and multiple risk factors.
Limitations
There are several limitations to this study. The first limitation is in the interpretation of changes in BNP levels over surgery. It is the lack of reliable estimates of volume overload and the aspect that a postoperative elevation of the BNP level is to the result of exposure to volume loading rather than to the progression of underlying cardiac disease. For example, in cases of orthopedic surgery with complicated lesions that require a larger volume of transfusion, the postoperative BNP level would be affected without doubt.
Second, owing to the fact that preoperative BNP levels have been noticed by clinicians prior to surgery for the purpose of managing patients, the results have been substantially confounded. Third, the preoperative BNP level is found to have no correlation with prolonged hospitalization. Also, it cannot be documented that postoperative BNP level is associated with clinical outcomes, such as death, heart failure, or late prognosis.
Last, long-term follow-up observations and studies on the mechanism of how non-cardiac surgeries could affect postoperative BNP levels are required.
